Counselors in Choteau, MT Accepting Medicare
6 Counselors found. Showing 1 - 6
 Raymond Robert Antonsen, MS, LAC Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 20 Othala Ln, Choteau, MT 59422 Phone: 406-466-2591 |
Mr. Lou Giles Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 121 Stott, Choteau, MT 59422 Phone: 406-466-3276 |
 Christine Michelle Gascon, LCPC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 316 1st Street Northwest, Center For Mental Health, Choteau, MT 59422 Phone: 406-466-5681 Fax: 406-791-9629 |
Jenna Moore Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 111 2nd Ave Nw, Choteau, MT 59422 Phone: 406-278-1452 |
Ms. Cheri Ann Peterson, LCSW,LMFT, LAC Counselor - Addiction (Substance Use Disorder) Medicare: Accepting Medicare Assignments Practice Location: 21 1st St Nw # 2, Choteau, MT 59422 Phone: 406-868-6902 |
Sheila Marie Murray, LCPC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 21 1st St Nw # 22, Choteau, MT 59422 Phone: 406-314-8439 Fax: 406-296-5266 |
News Archive
Seniors get a boost reading bad news about the youth: Study
New research shows that the elderly prefer to read bad news about the youth. This is possibly because it makes them feel better about themselves say researchers.
Takeda resubmits alogliptin and fixed-dose combination therapy NDA to FDA
Takeda Pharmaceutical Company Limited announced today that Takeda Global Research & Development Center, Inc., resubmitted two New Drug Applications to the United States Food and Drug Administration for alogliptin and the fixed-dose combination therapy alogliptin/pioglitazone, which combines alogliptin with pioglitazone in a single tablet.
Long-term success rates of surgery to treat pelvic organ prolapse are lower than expected
Research conducted by the Pelvic Floor Disorders Network, an initiative funded by the National Institutes of Health, has revealed that the long-term success rates of a surgery to treat pelvic organ prolapse are lower than expected. Nearly one-third of women develop anatomic or symptomatic treatment failure within five years of undergoing sacrocolpopexy for pelvic organ prolapse, according to a study published in the May 15 issue of JAMA.
Incontinence prophylaxis shows potential in pelvic organ prolapse
Research from Taiwan suggests that combining trocar-guided transvaginal mesh surgery with a midurethral sling in the treatment of women with advanced pelvic organ prolapse could be an effective way to manage associated stress urinary incontinence.
New report reveals optimal way to detect young athletes at risk of sudden cardiac death
Although rare, sudden cardiac death in young athletes raises serious concerns, especially because most victims report no warning symptoms. Pre-participation screening aims to identify children, adolescents, and young adults at risk, but there is not yet consensus regarding the best way to accomplish this.
› Verified 8 days ago